ENDO USA, Inc. — FDA Class II (D-0527-2026)

ENDO USA, Inc. is recalling 34,293 vials of a human prescription drug due to crystallization issues. This recall is classified as a safety issue and affects products administered intramuscularly and intravenously. The recall is part of the FDA's enforcement actions to ensure drug safety.

• •ENDO USA, Inc. is recalling 34,293 vials of a prescription drug.
• •The recall is due to crystallization issues.
• •The product is administered intramuscularly and intravenously.
• •Patients should check for affected vials to avoid health risks.
• •Class I recalls indicate serious safety concerns.

Patients who have received this drug should verify if they have the recalled vials. The recall affects 34,293 vials, which could pose serious health risks.